Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024
Period Ending	Sep 30, 2025	Sep 30, 2024
Cash & Equivalents	1.17	0.13
Cash & Short-Term Investments	1.17	0.13
Cash Growth	795.55%	-
Accounts Receivable	16.93	40.44
Other Receivables	9.63	12.61
Total Trade Receivables	26.56	53.05
Inventory	0.44	0.13
Other Current Assets	35.52	-
Total Current Assets	63.7	53.31
Net Property, Plant & Equipment	0.47	0.82
Other Long-Term Assets	4.25	2.72
Total Assets	68.41	56.85
Accounts Payable	9.41	15.06
Accrued Expenses	3.22	36.17
Short-Term Debt	10	10
Current Portion of Leases	0.37	0.35
Unearned Revenue	0.07	1.67
Other Current Liabilities	-	0.33
Total Current Liabilities	23.08	63.58
Long-Term Leases	0.1	0.46
Total Long-Term Liabilities	0.1	0.46
Total Liabilities	23.17	64.04
Common Stock	0.01	0.01
Accumulated Other Comprehensive Income	-1.61	-0.66
Retained Earnings	-19.37	-6.54
Shareholders' Equity	45.24	-7.19
Total Liabilities & Equity	68.41	56.85
Total Debt	10.47	10.81
Net Cash (Debt)	-9.3	-10.68
Net Cash Per Share	-0.50	-0.59
Book Value	45.24	-7.19
Book Value Per Share	2.45	-0.40
Tangible Book Value	45.24	-7.19
Tangible Book Value Per Share	2.45	-0.40

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.